Impact of the SARS-CoV-2 Virus Pandemic on Patients with Bronchiectasis: A Multicenter Study.

Infection by SARS-CoV-2 has unquestionably had an impact on the health of patients with chronic respiratory airway diseases, such as COPD and asthma, but little information is available about its impact on patients with bronchiectasis. The objective of the present study was to analyze the effect of...

ver descrição completa

Detalhes bibliográficos
Autores: Martínez-Vergara, Adrián, Girón Moreno, Rosa Mª, Olveira, Casilda, Victoria Girón, María, Peláez, Adrián, Ancochea, Julio, Oscullo, Grace, Martínez-García, Miguel Ángel
Tipo de documento: artigo
Data de publicação:2022
País:España
Recursos:Instituto de Salud Carlos III (ISCIII)
Repositório:Repisalud
Idioma:inglês
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/18737
Acesso em linha:http://hdl.handle.net/20.500.12105/18737
Access Level:Acceso aberto
Palavra-chave:BSI
COVID-19
E-FACED
Haemophilus influenza
Pseudomonas aeruginosa
SARS-CoV-2
bronchiectasis
exacerbation
pandemic
id ES_b70b6b58bb50f90b7eb3fca0779e2b6c
oai_identifier_str oai:repisalud.isciii.es:20.500.12105/18737
network_acronym_str ES
network_name_str España
repository_id_str
spelling Impact of the SARS-CoV-2 Virus Pandemic on Patients with Bronchiectasis: A Multicenter Study.Martínez-Vergara, AdriánGirón Moreno, Rosa MªOlveira, CasildaVictoria Girón, MaríaPeláez, AdriánAncochea, JulioOscullo, GraceMartínez-García, Miguel ÁngelBSICOVID-19E-FACEDHaemophilus influenzaPseudomonas aeruginosaSARS-CoV-2bronchiectasisexacerbationpandemicInfection by SARS-CoV-2 has unquestionably had an impact on the health of patients with chronic respiratory airway diseases, such as COPD and asthma, but little information is available about its impact on patients with bronchiectasis. The objective of the present study was to analyze the effect of the SARS-CoV-2 pandemic on the state of health, characteristics, and clinical severity (including the number and severity of exacerbations) of patients with non-cystic fibrosis bronchiectasis. This study was multicenter, observational, and ambispective (with data collected before and during the SARS-CoV-2 pandemic), and included 150 patients diagnosed with non-cystic fibrosis bronchiectasis. A significant drop was observed in the number and severity of the exacerbations (57% in all exacerbations and 50% in severe exacerbations) in the E-FACED and BSI multidimensional scores, in the pandemic, compared with the pre-pandemic period. There was also a drop in the percentage of sputum samples positive for pathogenic microorganisms in general (from 58% to 44.7%) and, more specifically, Pseudomonas aeruginosa (from 23.3% to 13.3%) and Haemophilus influenzae (from 21.3% to 14%). During the SARS-CoV-2 period, a significant reduction was observed in the exacerbations, severity, and isolations of pathogenic microorganisms in patients with bronchiectasis.20242024-02-2720222022-08-1220222022-08-12research articlehttp://purl.org/coar/resource_type/c_2df8fbb1VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articlehttp://hdl.handle.net/20.500.12105/18737reponame:Repisaludinstname:Instituto de Salud Carlos III (ISCIII)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2Attribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:repisalud.isciii.es:20.500.12105/187372026-06-12T12:43:37Z
dc.title.none.fl_str_mv Impact of the SARS-CoV-2 Virus Pandemic on Patients with Bronchiectasis: A Multicenter Study.
title Impact of the SARS-CoV-2 Virus Pandemic on Patients with Bronchiectasis: A Multicenter Study.
spellingShingle Impact of the SARS-CoV-2 Virus Pandemic on Patients with Bronchiectasis: A Multicenter Study.
Martínez-Vergara, Adrián
BSI
COVID-19
E-FACED
Haemophilus influenza
Pseudomonas aeruginosa
SARS-CoV-2
bronchiectasis
exacerbation
pandemic
title_short Impact of the SARS-CoV-2 Virus Pandemic on Patients with Bronchiectasis: A Multicenter Study.
title_full Impact of the SARS-CoV-2 Virus Pandemic on Patients with Bronchiectasis: A Multicenter Study.
title_fullStr Impact of the SARS-CoV-2 Virus Pandemic on Patients with Bronchiectasis: A Multicenter Study.
title_full_unstemmed Impact of the SARS-CoV-2 Virus Pandemic on Patients with Bronchiectasis: A Multicenter Study.
title_sort Impact of the SARS-CoV-2 Virus Pandemic on Patients with Bronchiectasis: A Multicenter Study.
dc.creator.none.fl_str_mv Martínez-Vergara, Adrián
Girón Moreno, Rosa Mª
Olveira, Casilda
Victoria Girón, María
Peláez, Adrián
Ancochea, Julio
Oscullo, Grace
Martínez-García, Miguel Ángel
author Martínez-Vergara, Adrián
author_facet Martínez-Vergara, Adrián
Girón Moreno, Rosa Mª
Olveira, Casilda
Victoria Girón, María
Peláez, Adrián
Ancochea, Julio
Oscullo, Grace
Martínez-García, Miguel Ángel
author_role author
author2 Girón Moreno, Rosa Mª
Olveira, Casilda
Victoria Girón, María
Peláez, Adrián
Ancochea, Julio
Oscullo, Grace
Martínez-García, Miguel Ángel
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv
dc.subject.none.fl_str_mv BSI
COVID-19
E-FACED
Haemophilus influenza
Pseudomonas aeruginosa
SARS-CoV-2
bronchiectasis
exacerbation
pandemic
topic BSI
COVID-19
E-FACED
Haemophilus influenza
Pseudomonas aeruginosa
SARS-CoV-2
bronchiectasis
exacerbation
pandemic
description Infection by SARS-CoV-2 has unquestionably had an impact on the health of patients with chronic respiratory airway diseases, such as COPD and asthma, but little information is available about its impact on patients with bronchiectasis. The objective of the present study was to analyze the effect of the SARS-CoV-2 pandemic on the state of health, characteristics, and clinical severity (including the number and severity of exacerbations) of patients with non-cystic fibrosis bronchiectasis. This study was multicenter, observational, and ambispective (with data collected before and during the SARS-CoV-2 pandemic), and included 150 patients diagnosed with non-cystic fibrosis bronchiectasis. A significant drop was observed in the number and severity of the exacerbations (57% in all exacerbations and 50% in severe exacerbations) in the E-FACED and BSI multidimensional scores, in the pandemic, compared with the pre-pandemic period. There was also a drop in the percentage of sputum samples positive for pathogenic microorganisms in general (from 58% to 44.7%) and, more specifically, Pseudomonas aeruginosa (from 23.3% to 13.3%) and Haemophilus influenzae (from 21.3% to 14%). During the SARS-CoV-2 period, a significant reduction was observed in the exacerbations, severity, and isolations of pathogenic microorganisms in patients with bronchiectasis.
publishDate 2022
dc.date.none.fl_str_mv 2022
2022-08-12
2022
2022-08-12
2024
2024-02-27
dc.type.none.fl_str_mv research article
http://purl.org/coar/resource_type/c_2df8fbb1
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv http://hdl.handle.net/20.500.12105/18737
url http://hdl.handle.net/20.500.12105/18737
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repisalud
instname:Instituto de Salud Carlos III (ISCIII)
instname_str Instituto de Salud Carlos III (ISCIII)
reponame_str Repisalud
collection Repisalud
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869417496561319936
score 15,811543

Registros relacionados